Physiopathology of somatolactotroph cells: from transduction mechanisms to cotargeting therapy. - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Annals of the New York Academy of Sciences Année : 2011

Physiopathology of somatolactotroph cells: from transduction mechanisms to cotargeting therapy.

Résumé

In pituitary somatolactotroph cells, G protein-coupled receptors and receptor tyrosine kinases binding their specific ligands trigger an enzymatic cascade that converges to MAP kinase activation in the subcellular compartment. Different signaling pathways, such as AC/cAMP/PKA and PI3K/Akt pathways, interact with MAP kinase to regulate key physiological functions, such as hormonal secretion and cell proliferation. Abnormalities affecting these signaling pathways have been identified as preponderant factors of pituitary tumorigenesis. In addition to trans-sphenoidal surgery, somatostatin analogs are used to control hormonal hypersecretion in GH-secreting adenomas. However, a subset of these tumors remains uncontrolled with these treatFments, calling for new therapeutic approaches. In these cases, novel multivalent somatostatin analogs or new somatostatin-dopamine chimeric molecules could be of interest. Another attractive therapeutic approach may be to use one or several inhibitors acting downstream in the signaling pathway, such as mammalian target of rapamycin inhibitor. Cotargeting therapy and gene therapy are promising tools for these problematic pituitary tumors.

Dates et versions

hal-00625456 , version 1 (21-09-2011)

Identifiants

Citer

Thomas Cuny, Corinne Gerard, Alexandru Saveanu, Anne A. Barlier, Alain Enjalbert. Physiopathology of somatolactotroph cells: from transduction mechanisms to cotargeting therapy.. Annals of the New York Academy of Sciences, 2011, 1220, pp.60-70. ⟨10.1111/j.1749-6632.2010.05924.x⟩. ⟨hal-00625456⟩

Collections

CNRS UNIV-AMU
44 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More